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In recent publications in Nature and PNAS, Rada-Iglesias et al. (2010) and Creyghton et al. (2010) have uncov-
ered unique chromatin signatures of developmental enhancers marking active, primed, or silent genes in
human and mouse embryonic stem cells.Cellular development is both multistep
and coordinated so that different subsets
of genes are turned on and off in a stage-
and tissue-specific manner. Although
changes in gene expression are regulated
by transcription factors that recognize
specific DNA sequences, epigenetic
modifications that are intimately associ-
ated with DNA also have an impact on
expression as they can promote or hinder
the accessibility of these factors to
regulatory elements within genes. In
this context, the epigenetic marks that
surround promoter and insulator elements
have been extensively studied in many
cell types while enhancer elements,
because of difficulties in their identifica-
tion, have until very recently remained
elusive.
Over the last decade, genome-wide
profiling of chromatin modifications in
embryonic stem cells (ESCs) and special-
ized cells has begun to uncover a new
genomic landscape in which predictors
of gene activity, silencing, and priming
can be deciphered on the basis of
methylated cytosine, modified histones,
and transcriptional machinery binding.
Enhancers were originally defined as
DNA encoded regulatory elements that
could improve the transcription of target
genes independently of both orientation
and position. These important but poorly
understood regulators were known to
exert effects over huge distances and, in
some instances, could even influence
the expression of allelic genes located
on independent chromosomes (Heintz-
man and Ren, 2009). In the past, the
identification of enhancers often relied
upon the discovery of disease-associated
mutations occurring at a considerable
distance from the candidate genes them-128 Cell Stem Cell 8, February 4, 2011 ª2011selves, for example, deletions and
rearrangements of human B-globin loci
in patients with thalassaemias. More
recently, combinatorial chromatin signa-
tures in which monomethylation of
histone H3 lysine 4 (H3K4me1), acetyla-
tion of histone H3 lysine 27 (H3K27ac),
and histone acetyltransferase/transcrip-
tional coactivator p300 binding coincide,
has revolutionized the search for tissue-
specific gene enhancers (Heintzman
et al., 2007; Visel et al., 2009). This break-
through, together with two recent studies
published at the end of last year
(Creyghton et al., 2010; Rada-Iglesias
et al., 2010), has allowed the repertoire
of distal regulatory enhancer elements to
be glimpsed for the first time.
Creyghton and colleagues identified
putative enhancers on the basis of
H3K4me1 and H3K27ac enrichment and
found substantial differences between
ESCs and more specialized cells. They
found that H3K27ac marking of these
regions correlated with overt transcrip-
tional activity of proximal genes and
speculated that a lack of H3K27ac might
correspond to a primed state, somewhat
analogous to the transcriptionally poised
or bivalent chromatin (H3K4me3/
H3K27me3) domains of the promoters
for many developmental regulator genes
in ESCs (Azuara et al., 2006; Bernstein
et al., 2006). Rada-Iglesias et al.
supported and substantially extended
these ideas by defining two classes of
putative enhancers, both enriched for
p300 and H3K4me1 and depleted
for H3K4me3, which displayed mutu-
ally exclusive marks: either H3K27ac
or H3K27me3. Elements marked by
H3K27ac included previously character-
ized enhancers of human ESC-specificElsevier Inc.genes such as OCT4 and NANOG,
as well as new elements associated
with highly expressed epiblast-specific
genes. In contrast, elements enriched
for H3K27me3 represented poorly ex-
pressed genes that were implicated in
early developmental stages, including
gastrulation, germ layer formation, and
early somitogenesis. This latter group,
which included NODAL, EOMES, LEFTY,
SOX, FOX, and WNT, had classical biva-
lent (H3K4me3/H3K27me3) marks at their
promoters in ESCs, and this state was
resolved upon ESC differentiation to
neuroepithelium, at both enhancers (by
H3K27me3 loss and H3K27ac gain)
and promoters (by H3K27me3 loss) of
neuronal-specific genes.
Whether and how these epigenetic
changes at enhancers and promoters
are coordinated remains to be charac-
terized. Nonetheless, such studies will
allow transient intermediates—based on
specific enhancer/promoter states—to
be defined and studied and to explore
the role of enhancers in fine tuning tran-
scriptional outputs toward directed
cellular fates. In zebrafish, Rada-Iglesias
et al. demonstrated that enhancers alone
could activate transcription in a cell-type
and stage-specific manner characteristic
of their proximal target genes, a result
that underscores the importance of these
elements in switching developmental
gene expression in vivo. Since enhancer
elements were able to regulate gene
expression in a highly specific manner,
a central issue is how such specificity is
achieved. Identifying the DNA-binding
factors that recognize enhancer elements
in different cell types will be essential
if future studies are to successfully
integrate signaling and transcriptional
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netic landscape.
A second question concerns themolec-
ular mechanisms by which enhancers
affect the transcription of distal genes.
Although the occurrence of long-range
chromatin interactions is now well estab-
lished, it remains unclear how contact is
initiated and how the transcriptional
output of genes is modified by the prox-
imity of distal regulatory regions. Recent
work showing that cohesin and Mediator
co-occupy distal regulatory elements of
specific sets of genes in ESCs and differ-
entiated cells (Kagey et al., 2010) may
provide some clues. The cohesin complex
is postulated to bring together enhancers
and promoters by a threading mechanism
in which Mediator-bound DNA is brought
into close proximity of the transcription
start site, perhaps affecting the recruit-
ment of the RNA polymerase II or the
activity of a prebound enzyme.
Despite huge progress on several
fronts, we do not yet understand how
chromatin remodelers are recruited to
specific enhancers in different cell types.
Both Creyghton et al. and Rada-Iglesias
et al. showed evidence of bidirec-
tional transcription from some enhancer
elements. It is, therefore, tempting to
speculate that noncoding RNAs might
have a role in regulating transcription
through the remodeling of chromatin, ashas been shown previously for hetero-
chromatin formation in yeast or X chromo-
some inactivation in mammals. Interest-
ingly, Rada-Iglesias et al. showed that
Suz12, a component of Polycomb
Repressor Complex 2, binds to primed
enhancers. Recent work has also shown
that Suz12 interacts with the stem-loop
of short noncoding RNAs that are tran-
scribed from the promoters of Polycomb
target genes in ESCs as well as in T cells
(Kanhere et al., 2010). Folding of short
RNAs into conserved stem-loop and
triple-stranded RNA:DNA structures is
known to be required for the recruitment
of NoRC complex and Dnmt3b and
silencing of rDNA genes in human and
mouse cell lines (Schmitz et al., 2010).
Whether short RNAs that are transcribed
from enhancers regulate the function of
these enhancers is a fascinating proposal
and one that will undoubtedly occupy
many of us for the foreseeable future.
Although a complete understanding of
enhancer repertoire and function remains
a distant goal, recent rapid progress
suggests that the enigmatic status of
these distal regulatory sequences is now
ripe to be challenged.REFERENCES
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